- Home
- EWTX vs SBH Comparison
EWTX vs SBH Comparison
Compare EWTX & SBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- SBH
- Stock Information
- Founded
- EWTX 2017
- SBH 1964
- Country
- EWTX United States
- SBH United States
- Employees
- EWTX N/A
- SBH N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- SBH Other Specialty Stores
- Sector
- EWTX Health Care
- SBH Consumer Discretionary
- Exchange
- EWTX Nasdaq
- SBH Nasdaq
- Market Cap
- EWTX 1.5B
- SBH 1.4B
- IPO Year
- EWTX 2021
- SBH 2006
- Fundamental
- Price
- EWTX $15.57
- SBH $14.49
- Analyst Decision
- EWTX Buy
- SBH Buy
- Analyst Count
- EWTX 9
- SBH 5
- Target Price
- EWTX $39.89
- SBH $12.88
- AVG Volume (30 Days)
- EWTX 782.1K
- SBH 2.2M
- Earning Date
- EWTX 08-07-2025
- SBH 08-05-2025
- Dividend Yield
- EWTX N/A
- SBH N/A
- EPS Growth
- EWTX N/A
- SBH 35.04
- EPS
- EWTX N/A
- SBH 1.85
- Revenue
- EWTX N/A
- SBH $3,689,376,000.00
- Revenue This Year
- EWTX N/A
- SBH $0.13
- Revenue Next Year
- EWTX N/A
- SBH $1.29
- P/E Ratio
- EWTX N/A
- SBH $7.79
- Revenue Growth
- EWTX N/A
- SBH N/A
- 52 Week Low
- EWTX $10.60
- SBH $7.54
- 52 Week High
- EWTX $38.12
- SBH $14.79
- Technical
- Relative Strength Index (RSI)
- EWTX 64.68
- SBH 70.11
- Support Level
- EWTX $13.93
- SBH $13.91
- Resistance Level
- EWTX $15.12
- SBH $14.53
- Average True Range (ATR)
- EWTX 0.71
- SBH 0.50
- MACD
- EWTX 0.10
- SBH -0.01
- Stochastic Oscillator
- EWTX 90.29
- SBH 95.09
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.